Li SL - Search Results

1

Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization.

Li SL, Wang ZM, Xu C, Che FH, Hu XF, Cao R, Xie YN, Qiu Y, Shi HB, Liu B, Dai C, Yang J. Li SL, et al. Front Immunol. 2022 Apr 5;13:869050. doi: 10.3389/fimmu.2022.869050. eCollection 2022. Front Immunol. 2022. PMID: 35450076 Free PMC article.

2

PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.

Ma D, Duan W, Li Y, Wang Z, Li S, Gong N, Chen G, Chen Z, Wan C, Yang J. Ma D, et al. PLoS One. 2016 Mar 18;11(3):e0152087. doi: 10.1371/journal.pone.0152087. eCollection 2016. PLoS One. 2016. PMID: 26990974 Free PMC article.

3

The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.

Li YK, Ma DX, Wang ZM, Hu XF, Li SL, Tian HZ, Wang MJ, Shu YW, Yang J. Li YK, et al. Among authors: li sl. Pharmacol Res. 2018 May;131:102-111. doi: 10.1016/j.phrs.2018.03.004. Epub 2018 Mar 9. Pharmacol Res. 2018. PMID: 29530599

4

Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.

Wang Z, Wang M, Hu X, Li Y, Ma D, Li S, Zhao G, Xie Y, Shu Y, Yang J. Wang Z, et al. Transplantation. 2019 Mar;103(3):502-511. doi: 10.1097/TP.0000000000002448. Transplantation. 2019. PMID: 30211824

5

Daidzein ameliorated concanavalin A-induced liver injury through the Akt/GSK-3β/Nrf2 pathway in mice.

Li SL, Cao R, Hu XF, Xiong P, Zhao GY, Xie YN, Wang ZM, Li YK, Yang B, Yang J. Li SL, et al. Among authors: li yk. Ann Transl Med. 2021 Aug;9(15):1228. doi: 10.21037/atm-21-378. Ann Transl Med. 2021. PMID: 34532365 Free PMC article.

6

Pharmacological targeting macrophage phenotype via gut-kidney axis ameliorates renal fibrosis in mice.

Xie Y, Hu X, Li S, Qiu Y, Cao R, Xu C, Lu C, Wang Z, Yang J. Xie Y, et al. Pharmacol Res. 2022 Apr;178:106161. doi: 10.1016/j.phrs.2022.106161. Epub 2022 Mar 5. Pharmacol Res. 2022. PMID: 35259481

7

Glycyrrhizic acid improves tacrolimus-induced renal injury by regulating autophagy.

Cao R, Li Y, Hu X, Qiu Y, Li S, Xie Y, Xu C, Lu C, Chen G, Yang J. Cao R, et al. FASEB J. 2023 Feb;37(2):e22749. doi: 10.1096/fj.202201409RR. FASEB J. 2023. PMID: 36688808

8

Liraglutide abrogates nephrotoxic effects of chemotherapies.

Xu C, Lu C, Wang Z, Hu X, Li S, Xie Y, Qiu Y, Cao R, Li Y, Yang J. Xu C, et al. Pharmacol Res. 2023 Mar;189:106680. doi: 10.1016/j.phrs.2023.106680. Epub 2023 Feb 4. Pharmacol Res. 2023. PMID: 36746359 Free article.

9

Identification and Verification of Potential Biomarkers in Renal Ischemia-Reperfusion Injury by Integrated Bioinformatic Analysis.

Pan Z, Yang Y, Cao R, Qiu Y, Li S, Zhao Y, Chang S, Chen S, Chen Z, Zhang W, Zhao D. Pan Z, et al. Biomed Res Int. 2023 Feb 2;2023:7629782. doi: 10.1155/2023/7629782. eCollection 2023. Biomed Res Int. 2023. PMID: 36778059 Free PMC article.

10

Liraglutide and GLP-1(9-37) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3β/Nrf2 pathway and SMAD159/Hepcidin/FTH pathway.

Lu C, Xu C, Li S, Ni H, Yang J. Lu C, et al. Redox Biol. 2024 Dec 12;79:103468. doi: 10.1016/j.redox.2024.103468. Online ahead of print. Redox Biol. 2024. PMID: 39693850 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,664 results

Search Page

Filters